BakshiR. (1996). Fluoxetine and restless legs syndrome. Journal of Neurological Studies, 142 (1–2), 151–152.
2.
DinwiddieL. C. (1997). Restless legs syndrome: Not just a problem for dialysis patients. ANNA Journal, 24, 655–662.
3.
FraserC. L., & ArieffA. I. (1996). Nervous system manifestations of renal failure. In SchrierR. W. & GottshalkC. W. (Eds.), Diseases of the kidney (6th ed.). Boston: Little, Brown.
4.
HargraveR., & BeckleyD. J. (1998). Restless leg syndrome exacerbated by sertraline. Psychosomatics, 39, 177–178.
5.
JanzenL., RichJ. A., & VercaigneL. M. (1999). An overview of levadopa in the management of restless legs syndrome in a dialysis population: Pharmokinetices, clinical trials and complications of therapy. Annals of Pharmacotherapy, 33, 86–92.
6.
JohnL., KirubakaranM. G., & ShastryJ. C. (1987). Diabetic retinopathy: A clinical study of 498 patients. Journal of Diabetic Complications, 1, 87–90.
WalkerS., FineA., & KrygerM. H. (1995). Sleep complaints are common in a dialysis unit. American Journal of Kidney Diseases, 26, 751–756.
10.
WaltersA. S., & The International Restless Legs Syndrome Study. (1995). Toward a better definition of restless legs syndrome. Movement Disorders, 10, 634–642.
11.
WaltersA. S., HickeyK., MaltzmanJ., VerricoT., JosephD., HeningW., WilsonV., & ChokrovertyS. (1996). A questionnaire study of 138 patients with restless legs syndrome: The nightwalkers survey. Neurology, 46, 92–95.
12.
WilsonV., & ChokrovertyS. (1996). A questionnaire study of 138 patients with restless legs syndrome: The nightwalkers survey. Neurology, 46, 92–95.
13.
WinkelmanJ. W., ChertowG. M., & LazarusJ. M. (1996). Restless legs syndrome in end-stage renal disease. American Journal of Kidney Diseases, 28, 372–378.